{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:31:13Z","timestamp":1792103473881,"version":"4.4.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":80,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of\u00a0Hunan Province","doi-asserted-by":"publisher","award":["2026JJ50154"],"award-info":[{"award-number":["2026JJ50154"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Temozolomide (TMZ) resistance in glioblastoma (GBM) is often linked to high MGMT protein levels, but MGMT-deficient tumors can still acquire resistance, implicating MGMT-independent repair pathways. Here, we identify an oxidative stress-responsive LMO7\u2013ALKBH2 ubiquitination mechanism that regulates ALKBH2 stability and modulates alkylation damage tolerance in GBM. The E3 ligase LMO7 directly binds ALKBH2 and promotes K48-linked polyubiquitination and proteasomal degradation of ALKBH2, with Lys7 serving as a major ubiquitin acceptor site. Oxidative stress enhances LMO7-dependent ALKBH2 ubiquitination through NEDD8-dependent cullin neddylation, reducing TMZ-induced ALKBH2 accumulation and increasing TMZ sensitivity. The K7R substitution attenuates LMO7- and oxidative stress-induced ALKBH2 polyubiquitination and degradation and weakens LMO7-dependent TMZ sensitization. Functionally, ALKBH2 depletion sensitizes MGMT-deficient GBM cells to TMZ and methyl methanesulfonate, whereas ALKBH2 re-expression restores alkylator tolerance. In patient datasets, ALKBH2 protein levels are elevated in GBM and inversely associated with MGMT protein levels, an association not detected at the mRNA level. High\n                    <jats:italic>ALKBH2<\/jats:italic>\n                    expression in chemotherapy-treated IDH-wild-type glioma and low\n                    <jats:italic>LMO7<\/jats:italic>\n                    expression in the CGGA astrocytoma cohort are each associated with shorter overall survival. Together, these results indicate that oxidative stress-coupled LMO7-dependent polyubiquitination of ALKBH2 modulates TMZ sensitivity in GBM, particularly in MGMT-deficient tumors.\n                  <\/jats:p>","DOI":"10.1038\/s41419-026-09073-6","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T11:50:15Z","timestamp":1782820215000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["E3 ligase LMO7 promotes ALKBH2 ubiquitination to sensitize MGMT-deficient glioblastoma to temozolomide"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-0937-2815","authenticated-orcid":false,"given":"Zhiming","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyuan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chujing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3618-310X","authenticated-orcid":false,"given":"Zhaohui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiabing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqiao","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyao","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9856-3917","authenticated-orcid":false,"given":"Yu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"9073_CR1","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987\u201396.","journal-title":"N Engl J Med"},{"key":"9073_CR2","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1093\/neuonc\/noaa214","volume":"23","author":"Y Wei","year":"2021","unstructured":"Wei Y, Lu C, Zhou P, Zhao L, Lyu X, Yin J, et al. EIF4A3-induced circular RNA ASAP1 promotes tumorigenesis and temozolomide resistance of glioblastoma via NRAS\/MEK1\/ERK1-2 signaling. Neuro Oncol. 2021;23:611\u201324.","journal-title":"Neuro Oncol"},{"key":"9073_CR3","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1001\/jama.2013.280319","volume":"310","author":"A Omuro","year":"2013","unstructured":"Omuro A. DeAngelis LM. Glioblastoma and other malignant gliomas: a clinical review. J Am Med Assoc. 2013;310:1842\u201350.","journal-title":"J Am Med Assoc"},{"key":"9073_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.388","volume":"4","author":"CH Fan","year":"2013","unstructured":"Fan CH, Liu WL, Cao H, Wen C, Chen L, Jiang G. O6-methylguanine DNA methyltransferase as a promising target for the treatment of temozolomide-resistant gliomas. Cell Death Dis. 2013;4:e876.","journal-title":"Cell Death Dis"},{"key":"9073_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/nrneurol.2009.197","volume":"6","author":"M Weller","year":"2010","unstructured":"Weller M, Stupp R, Reifenberger G, Brandes AA, van den Bent MJ, Wick W, et al. MGMT promoter methylation in malignant gliomas: ready for personalized medicine? Nat Rev Neurol. 2010;6:39\u201351.","journal-title":"Nat Rev Neurol"},{"key":"9073_CR6","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1093\/brain\/awz202","volume":"142","author":"GZ Yi","year":"2019","unstructured":"Yi GZ, Huang G, Guo M, Zhang X, Wang H, Deng S, et al. Acquired temozolomide resistance in MGMT-deficient glioblastoma cells is associated with regulation of DNA repair by DHC2. Brain. 2019;142:2352\u201366.","journal-title":"Brain"},{"key":"9073_CR7","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ccell.2018.06.006","volume":"34","author":"ZA Binder","year":"2018","unstructured":"Binder ZA, Thorne AH, Bakas S, Wileyto EP, Bilello M, Akbari H, et al. Epidermal growth factor receptor extracellular domain mutations in glioblastoma present opportunities for clinical imaging and therapeutic development. Cancer Cell. 2018;34:163\u2013177.e167.","journal-title":"Cancer Cell"},{"key":"9073_CR8","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1002\/ijc.25229","volume":"127","author":"M Christmann","year":"2010","unstructured":"Christmann M, Nagel G, Horn S, Krahn U, Wiewrodt D, Sommer C, et al. MGMT activity, promoter methylation and immunohistochemistry of pretreatment and recurrent malignant gliomas: a comparative study on astrocytoma and glioblastoma. Int J Cancer. 2010;127:2106\u201318.","journal-title":"Int J Cancer"},{"key":"9073_CR9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0305-7372(97)90019-0","volume":"23","author":"ES Newlands","year":"1997","unstructured":"Newlands ES, Stevens MF, Wedge SR, Wheelhouse RT, Brock C. Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials. Cancer Treat Rev. 1997;23:35\u201361.","journal-title":"Cancer Treat Rev"},{"key":"9073_CR10","doi-asserted-by":"publisher","first-page":"6394","DOI":"10.1158\/0008-5472.CAN-05-0715","volume":"65","author":"RN Trivedi","year":"2005","unstructured":"Trivedi RN, Almeida KH, Fornsaglio JL, Schamus S, Sobol RW. The role of base excision repair in the sensitivity and resistance to temozolomide-mediated cell death. Cancer Res. 2005;65:6394\u2013400.","journal-title":"Cancer Res"},{"key":"9073_CR11","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.tibs.2016.10.001","volume":"42","author":"JM Soll","year":"2017","unstructured":"Soll JM, Sobol RW, Mosammaparast N. Regulation of DNA alkylation damage repair: lessons and therapeutic opportunities. Trends Biochem Sci. 2017;42:206\u201318.","journal-title":"Trends Biochem Sci"},{"key":"9073_CR12","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s11060-009-9837-0","volume":"94","author":"V Cetica","year":"2009","unstructured":"Cetica V, Genitori L, Giunti L, Sanzo M, Bernini G, Massimino M, et al. Pediatric brain tumors: mutations of two dioxygenases (hABH2 and hABH3) that directly repair alkylation damage. J Neurooncol. 2009;94:195\u2013201.","journal-title":"J Neurooncol"},{"key":"9073_CR13","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1038\/nature06889","volume":"452","author":"CG Yang","year":"2008","unstructured":"Yang CG, Yi C, Duguid EM, Sullivan CT, Jian X, Rice PA, et al. Crystal structures of DNA\/RNA repair enzymes AlkB and ABH2 bound to dsDNA. Nature. 2008;452:961\u20135.","journal-title":"Nature"},{"key":"9073_CR14","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1038\/sj.emboj.7601109","volume":"25","author":"J Ringvoll","year":"2006","unstructured":"Ringvoll J, Nordstrand LM, V\u00e5gb\u00f8 CB, Talstad V, Reite K, Aas PA, et al. Repair deficient mice reveal mABH2 as the primary oxidative demethylase for repairing 1meA and 3meC lesions in DNA. EMBO J. 2006;25:2189\u201398.","journal-title":"EMBO J"},{"key":"9073_CR15","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1093\/neuonc\/nos301","volume":"15","author":"TC Johannessen","year":"2013","unstructured":"Johannessen TC, Prestegarden L, Grudic A, Hegi ME, Tysnes BB, Bjerkvig R. The DNA repair protein ALKBH2 mediates temozolomide resistance in human glioblastoma cells. Neuro Oncol. 2013;15:269\u201378.","journal-title":"Neuro Oncol"},{"key":"9073_CR16","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.dnarep.2019.04.007","volume":"78","author":"B Kaina","year":"2019","unstructured":"Kaina B, Christmann M. DNA repair in personalized brain cancer therapy with temozolomide and nitrosoureas. DNA Repair (Amst). 2019;78:128\u201341.","journal-title":"DNA Repair (Amst)"},{"key":"9073_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07969-3","volume":"16","author":"J Li","year":"2025","unstructured":"Li J, Feng X, Liu Z, Deng Y, Sun Z, Chen B, et al. USP7 promotes temozolomide resistance by stabilizing MGMT in glioblastoma. Cell Death Dis. 2025;16:631.","journal-title":"Cell Death Dis"},{"key":"9073_CR18","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.3390\/biomedicines13061479","volume":"13","author":"O Switzeny","year":"2025","unstructured":"Switzeny O, Pusch S, Christmann M, Kaina B. IDH1 mutation impacts DNA repair through ALKBH2 rendering glioblastoma cells sensitive to artesunate. Biomedicines. 2025;13:1479.","journal-title":"Biomedicines"},{"key":"9073_CR19","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1016\/j.celrep.2015.11.029","volume":"13","author":"P Wang","year":"2015","unstructured":"Wang P, Wu J, Ma S, Zhang L, Yao J, Hoadley KA, et al. Oncometabolite D-2-hydroxyglutarate inhibits ALKBH DNA repair enzymes and sensitizes IDH mutant cells to alkylating agents. Cell Rep. 2015;13:2353\u201361.","journal-title":"Cell Rep"},{"key":"9073_CR20","first-page":"70","volume":"11","author":"A Malacrida","year":"2022","unstructured":"Malacrida A, Di Domizio A, Bentivegna A, Cislaghi G, Messuti E, Tabano SM, et al. MV1035 overcomes temozolomide resistance in patient-derived glioblastoma stem cell lines. Biol (Basel). 2022;11:70.","journal-title":"Biol (Basel)"},{"key":"9073_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.117054","volume":"282","author":"K Xu","year":"2025","unstructured":"Xu K, Li F, Xiong L, Guo Y, Zhang J, Wang Y, et al. Discovery and structure-activity relationship study of nicotinamide derivatives as DNA demethylase ALKBH2 inhibitors. Eur J Med Chem. 2025;282:117054.","journal-title":"Eur J Med Chem"},{"key":"9073_CR22","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s11030-022-10444-2","volume":"27","author":"UP Shaji","year":"2023","unstructured":"Shaji UP, Tuti N, Das S, Anindya R, Mohan M. Interactions between HIV protease inhibitor ritonavir and human DNA repair enzyme ALKBH2: a molecular dynamics simulation study. Mol Divers. 2023;27:931\u20138.","journal-title":"Mol Divers"},{"key":"9073_CR23","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1038\/sj.cdd.4401702","volume":"12","author":"A Hershko","year":"2005","unstructured":"Hershko A. The ubiquitin system for protein degradation and some of its roles in the control of the cell division cycle. Cell Death Differ. 2005;12:1191\u20137.","journal-title":"Cell Death Differ"},{"key":"9073_CR24","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/416703a","volume":"416","author":"N Zheng","year":"2002","unstructured":"Zheng N, Schulman BA, Song L, Miller JJ, Jeffrey PD, Wang P, et al. Structure of the Cul1-Rbx1-Skp1-F boxSkp2 SCF ubiquitin ligase complex. Nature. 2002;416:703\u20139.","journal-title":"Nature"},{"key":"9073_CR25","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202402816RR","volume":"39","author":"X Zeng","year":"2025","unstructured":"Zeng X, Cao J, Xu J, Zhou Z, Long C, Zhou Y, et al. SKP1-CUL1-F-box: key molecular targets affecting disease progression. FASEB J. 2025;39:e70326.","journal-title":"FASEB J"},{"key":"9073_CR26","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/s41420-022-01143-w","volume":"8","author":"Y Wang","year":"2022","unstructured":"Wang Y, Shen X, Gong L, Zhao Y, Xiong X. Functional characterization of FBXL7 as a novel player in human cancers. Cell Death Discov. 2022;8:342.","journal-title":"Cell Death Discov"},{"key":"9073_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06425-y","volume":"15","author":"K Chen","year":"2024","unstructured":"Chen K, Wang Y, Dai X, Luo J, Hu S, Zhou Z, et al. FBXO31 is upregulated by METTL3 to promote pancreatic cancer progression via regulating SIRT2 ubiquitination and degradation. Cell Death Dis. 2024;15:37.","journal-title":"Cell Death Dis"},{"key":"9073_CR28","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.freeradbiomed.2013.10.806","volume":"67","author":"T Wu","year":"2014","unstructured":"Wu T, Wang XJ, Tian W, Jaramillo MC, Lau A, Zhang DD. Poly(ADP-ribose) polymerase-1 modulates Nrf2-dependent transcription. Free Radic Biol Med. 2014;67:69\u201380.","journal-title":"Free Radic Biol Med"},{"key":"9073_CR29","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.15252\/embj.201490497","volume":"34","author":"Y Zhao","year":"2015","unstructured":"Zhao Y, Majid MC, Soll JM, Brickner JR, Dango S, Mosammaparast N. Noncanonical regulation of alkylation damage resistance by the OTUD4 deubiquitinase. EMBO J. 2015;34:1687\u2013703.","journal-title":"EMBO J"},{"key":"9073_CR30","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.7150\/thno.103629","volume":"15","author":"X Zhou","year":"2025","unstructured":"Zhou X, Xia Q, Wang B, Li J, Liu B, Wang S, et al. USP14 modulates stem-like properties, tumorigenicity, and radiotherapy resistance in glioblastoma stem cells through stabilization of MST4-phosphorylated ALKBH5. Theranostics. 2025;15:2293\u2013314.","journal-title":"Theranostics"},{"key":"9073_CR31","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1111\/jcmm.13056","volume":"21","author":"H Wu","year":"2017","unstructured":"Wu H, Zhou J, Mei S, Wu D, Mu Z, Chen B, et al. Circulating exosomal microRNA-96 promotes cell proliferation, migration and drug resistance by targeting LMO7. J Cell Mol Med. 2017;21:1228\u201336.","journal-title":"J Cell Mol Med"},{"key":"9073_CR32","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.lungcan.2018.09.017","volume":"125","author":"T Karlsson","year":"2018","unstructured":"Karlsson T, Kvarnbrink S, Holmlund C, Botling J, Micke P, Henriksson R, et al. LMO7 and LIMCH1 interact with LRIG proteins in lung cancer, with prognostic implications for early-stage disease. Lung Cancer. 2018;125:174\u201384.","journal-title":"Lung Cancer"},{"key":"9073_CR33","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00018-025-06052-6","volume":"83","author":"SH Choi","year":"2026","unstructured":"Choi SH, Cho K, Kim ES, Yoo HY. Interaction of CSN4 to DDB1 regulates its stability and function in DNA damage signaling. Cell Mol Life Sci. 2026;83:111.","journal-title":"Cell Mol Life Sci"},{"key":"9073_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-025-15345-9","volume":"26","author":"H Zhang","year":"2025","unstructured":"Zhang H, Gao M, Gao Z, Yao L, Sun H, Wang H, et al. Identification and validation of SUN modification-related anti-PD-1 immunotherapy-resistance signatures to predict prognosis and immune microenvironment status in glioblastoma. BMC Cancer. 2025;26:7.","journal-title":"BMC Cancer"},{"key":"9073_CR35","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1080\/15592294.2018.1504592","volume":"13","author":"O Oyinlade","year":"2018","unstructured":"Oyinlade O, Wei S, Kammers K, Liu S, Wang S, Ma D, et al. Analysis of KLF4 regulated genes in cancer cells reveals a role of DNA methylation in promoter- enhancer interactions. Epigenetics. 2018;13:751\u201368.","journal-title":"Epigenetics"},{"key":"9073_CR36","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nature24484","volume":"551","author":"JR Brickner","year":"2017","unstructured":"Brickner JR, Soll JM, Lombardi PM, V\u00e5gb\u00f8 CB, Mudge MC, Oyeniran C, et al. A ubiquitin-dependent signalling axis specific for ALKBH-mediated DNA dealkylation repair. Nature. 2017;551:389\u201393.","journal-title":"Nature"},{"key":"9073_CR37","doi-asserted-by":"publisher","unstructured":"Sun Z, Deng Y, Liu Y, Liu Z, Li J, Wu L, et al. A stress-dependent TRIM28\u2013ALKBH2 feedback loop modulates chemotherapy response. bioRxiv. 2025 https:\/\/doi.org\/10.1101\/2025.11.21.689678.","DOI":"10.1101\/2025.11.21.689678"},{"key":"9073_CR38","doi-asserted-by":"publisher","first-page":"D512","DOI":"10.1093\/nar\/gku1267","volume":"43","author":"PV Hornbeck","year":"2015","unstructured":"Hornbeck PV, Zhang B, Murray B, Kornhauser JM, Latham V, Skrzypek E. PhosphoSitePlus, 2014: mutations, PTMs and recalibrations. Nucleic Acids Res. 2015;43:D512\u2013520.","journal-title":"Nucleic Acids Res"},{"key":"9073_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30707-8","volume":"13","author":"D Wu","year":"2022","unstructured":"Wu D, Li H, Liu M, Qin J, Sun Y. The Ube2m-Rbx1 neddylation-Cullin-RING-Ligase proteins are essential for the maintenance of Regulatory T cell fitness. Nat Commun. 2022;13:3021.","journal-title":"Nat Commun"},{"key":"9073_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-08255-y","volume":"17","author":"N Deng","year":"2026","unstructured":"Deng N, Sun Q, Yu X, Li T, Sun J, Jia S, et al. Decoding neddylation in malignancies: molecular mechanisms, biological functions, therapeutic resistance, and clinical potential. Cell Death Dis. 2026;17:37.","journal-title":"Cell Death Dis"},{"key":"9073_CR41","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13045-023-01485-7","volume":"16","author":"DJ Fu","year":"2023","unstructured":"Fu DJ, Wang T. Targeting NEDD8-activating enzyme for cancer therapy: developments, clinical trials, challenges and future research directions. J Hematol Oncol. 2023;16:87.","journal-title":"J Hematol Oncol"},{"key":"9073_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.119911","volume":"241","author":"YJ He","year":"2020","unstructured":"He YJ, Liu XY, Xing L, Wan X, Chang X, Jiang HL. Fenton reaction-independent ferroptosis therapy via glutathione and iron redox couple sequentially triggered lipid peroxide generator. Biomaterials. 2020;241:119911.","journal-title":"Biomaterials"},{"key":"9073_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.134798","volume":"278","author":"S Yang","year":"2024","unstructured":"Yang S, Xing J, Liu D, Song Y, Yu H, Xu S, et al. Review and new insights into the catalytic structural domains of the Fe(ll) and 2-Oxoglutarate families. Int J Biol Macromol. 2024;278:134798.","journal-title":"Int J Biol Macromol"},{"key":"9073_CR44","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/neuonc\/noac238","volume":"25","author":"G Chang","year":"2023","unstructured":"Chang G, Xie GS, Ma L, Li P, Li L, Richard HT. USP36 promotes tumorigenesis and drug sensitivity of glioblastoma by deubiquitinating and stabilizing ALKBH5. Neuro Oncol. 2023;25:841\u201353.","journal-title":"Neuro Oncol"},{"key":"9073_CR45","doi-asserted-by":"publisher","first-page":"6658","DOI":"10.1007\/s12035-024-04001-1","volume":"61","author":"M Song","year":"2024","unstructured":"Song M, Yi F, Zeng F, Zheng L, Huang L, Sun X, et al. USP18 stabilized FTO protein to activate mitophagy in ischemic stroke through repressing m6A modification of SIRT6. Mol Neurobiol. 2024;61:6658\u201374.","journal-title":"Mol Neurobiol"},{"key":"9073_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.847821","volume":"12","author":"S Feng","year":"2022","unstructured":"Feng S, Xu Z, Peng J, Zhang M. The AlkB family: potential prognostic biomarkers and therapeutic targets in glioblastoma. Front Oncol. 2022;12:847821.","journal-title":"Front Oncol"},{"key":"9073_CR47","doi-asserted-by":"publisher","first-page":"4785","DOI":"10.1016\/j.apsb.2023.09.012","volume":"13","author":"S Duan","year":"2023","unstructured":"Duan S, Lou X, Chen S, Jiang H, Chen D, Yin R, et al. Macrophage LMO7 deficiency facilitates inflammatory injury via metabolic-epigenetic reprogramming. Acta Pharm Sin B. 2023;13:4785\u2013800.","journal-title":"Acta Pharm Sin B"},{"key":"9073_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.774435","volume":"12","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Liu Q, Cui M, Wang M, Hua S, Gao J, et al. Comprehensive analysis of expression, prognostic value, and immune infiltration for ubiquitination-related FBXOs in pancreatic ductal adenocarcinoma. Front Immunol. 2021;12:774435.","journal-title":"Front Immunol"},{"key":"9073_CR49","first-page":"00905","volume":"S2090-1232","author":"M Zhang","year":"2025","unstructured":"Zhang M, Qiu P, Feng Y, Yang T, Yao W, Deng Z. Neddylation: from regulatory mechanisms to clinical implications in cancer. J Adv Res. 2025;S2090-1232:00905\u20131.","journal-title":"J Adv Res"},{"key":"9073_CR50","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1007\/s00018-009-8712-7","volume":"66","author":"J Merlet","year":"2009","unstructured":"Merlet J, Burger J, Gomes JE, Pintard L. Regulation of cullin-RING E3 ubiquitin-ligases by neddylation and dimerization. Cell Mol Life Sci. 2009;66:1924\u201338.","journal-title":"Cell Mol Life Sci"},{"key":"9073_CR51","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1007\/s00018-023-04911-8","volume":"80","author":"Y Tian","year":"2023","unstructured":"Tian Y, Milic J, Monasor LS, Chakraborty R, Wang S, Yuan Y, et al. The COP9 signalosome reduces neuroinflammation and attenuates ischemic neuronal stress in organotypic brain slice culture model. Cell Mol Life Sci. 2023;80:262.","journal-title":"Cell Mol Life Sci"},{"key":"9073_CR52","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1093\/neuonc\/noaf265","volume":"28","author":"D Tiek","year":"2026","unstructured":"Tiek D, Song X, Wu R, Yu X, Walker M, Mao Y, et al. Cysteine addiction in drug resistant glioblastoma and therapeutic targeting with designer selenium compounds. Neuro Oncol. 2026;28:613\u201325.","journal-title":"Neuro Oncol"},{"key":"9073_CR53","doi-asserted-by":"publisher","first-page":"7092","DOI":"10.1158\/1078-0432.CCR-09-1349","volume":"15","author":"J Portnow","year":"2009","unstructured":"Portnow J, Badie B, Chen M, Liu A, Blanchard S, Synold TW. The neuropharmacokinetics of temozolomide in patients with resectable brain tumors: potential implications for the current approach to chemoradiation. Clin Cancer Res. 2009;15:7092\u20138.","journal-title":"Clin Cancer Res"},{"key":"9073_CR54","doi-asserted-by":"publisher","first-page":"3728","DOI":"10.1158\/1078-0432.CCR-03-0807","volume":"10","author":"S Ostermann","year":"2004","unstructured":"Ostermann S, Csajka C, Buclin T, Leyvraz S, Lejeune F, Decosterd LA, et al. Plasma and cerebrospinal fluid population pharmacokinetics of temozolomide in malignant glioma patients. Clin Cancer Res. 2004;10:3728\u201336.","journal-title":"Clin Cancer Res"},{"key":"9073_CR55","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1158\/2159-8290.CD-14-0157","volume":"4","author":"S Agnihotri","year":"2014","unstructured":"Agnihotri S, Burrell K, Buczkowicz P, Remke M, Golbourn B, Chornenkyy Y, et al. ATM regulates 3-methylpurine-DNA glycosylase and promotes therapeutic resistance to alkylating agents. Cancer Discov. 2014;4:1198\u2013213.","journal-title":"Cancer Discov"},{"key":"9073_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04590-6","volume":"13","author":"X Zhang","year":"2022","unstructured":"Zhang X, Li T, Yang M, Du Q, Wang R, Fu B, et al. Acquired temozolomide resistance in MGMT(low) gliomas is associated with regulation of homologous recombination repair by ROCK2. Cell Death Dis. 2022;13:138.","journal-title":"Cell Death Dis"},{"key":"9073_CR57","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.3390\/cancers14092233","volume":"14","author":"L Beltzig","year":"2022","unstructured":"Beltzig L, Schwarzenbach C, Leukel P, Frauenknecht KBM, Sommer C, Tancredi A, et al. Senescence is the main trait induced by temozolomide in glioblastoma cells. Cancers (Basel). 2022;14:2233.","journal-title":"Cancers (Basel)"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09073-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09073-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09073-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:48:09Z","timestamp":1789685289000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09073-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9073"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-09073-6","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"assertion":[{"value":"4 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This study did not involve experiments with human participants or animals.","order":2,"name":"Ethics","label":"Ethics statement","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"808"}}